Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at ZS's multiple
$7.7794.7% above market
0.94 ZNTL revenue / share×8.26x ZS P/S=$7.77
Market $3.99Implied $7.77
ZS · current priceP/S 8.26x
$169.80Latest market snapshot
Implied fair value · at ZNTL's multiple
$87.2048.6% below market
20.56 ZS revenue / share×4.24x ZNTL P/S=$87.20
Market $169.80Implied $87.20